Broadening participation in clinical trials: A win for all

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology

Commercial

Uncorking the compliance bottlenecks in digital

Making compliance processes fit for the digital age quickly moved from being merely an important problem to a mission critical one this...

Commercial

Blended and augmented: Reimagining the role of the rep

As pharma tentatively contemplates a post-pandemic future, it is clear that the old sales model has been swept away by this year’s...

Latest

Commercial
Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Commercial
Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology
Clinical
Maimah Karmo: Surviving, fighting, winning

Andrew Stone, (Nov 26, 2020)

The Tigerlily Foundation President and Founder is more hopeful than ever that she can help pharma give Black women the representation they deserve in trials and beyond
Medical
COVID-19: A data challenge and a catalyst for new insights

Andrew Stone, (Nov 24, 2020)

The healthcare ecosystem has demonstrated its ability to share data to uncover new insights this year but there is more to be done, says Nigel Hughes, scientific director at Epidemiology, Janssen R&D
Patients and Medical
Building a health equity culture

Andrew Stone, (Nov 17, 2020)

Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts

Opinion

Up Close and Personal: A Life of Service - The Dr. Dirk Vander Mijnsbrugge Story

Jill Donahue, (Oct 2, 2020)

Pfizer's Medical Affairs Lead, Rare Diseases, talks about purpose, patients and pharma's power to do good

Up close and personal: The Thomas D’Hooghe story

Jill Donahue, (Apr 14, 2020)

Merck's Thomas D’Hooghe shares his thoughts on passion, purpose, leading people and making a difference

More Columns

Commercial

Blended and augmented: Reimagining the role of the rep

Andrew Stone, (Dec 18, 2020)

The events of 2020 have compelled pharma to reimagine the role of the rep to better adapt to the new rules of engagement
Uncorking the compliance bottlenecks in digital

Andrew Stone, (Dec 17, 2020)

The sudden demand for digital content this year has created serious compliance bottlenecks that pharma is racing to overcome with new processes and technology
Creating a holistic customer experience

Rhonda Siddall, (Nov 17, 2020)

Finding solutions to unmet customer needs means harnessing the combined power of medical and marketing skills – and creating a culture to match
Adapting to the multichannel imperative: A special report

Andrew Stone, (Oct 8, 2020)

Pharma’s gradual evolution into digital-first commercial has become urgent in the COVID-19 world. A comprehensive multi-channel approach including the use of digital tools to enhance customer engagement will transform pharma sales.
Australia’s field force: evolving on fast forward

Lucy Fulford, (Sep 16, 2020)

Australian pharma’s field force roles are changing fast and the new digital-first environment is driving a need for new approaches and new skillsets

More Commercial

Access and Evidence

A burning desire to make a difference for patients

Andrew Stone, (Apr 19, 2020)

Annexus Health, eyeforpharma’s 2020 Health Start-up winner is on a mission for patients
From reactive to predictive: Concerto’s new compositions

Andrew Stone, (Apr 10, 2020)

Artificial Intelligence has only just begun to unlock high value innovation. The latest predictive tools will break new ground, says Concerto HealthAI’s Jeff Elton
Evolving HTA frameworks to accelerate innovation

Andrew Stone, (Mar 14, 2020)

Iterative evidence generation and demonstrating value over time could help unlock delays in getting cures out, saving more lives, says Janssen’s Clare Hague
Can we afford to pay for future cures?

Ulrich Neumann, (Jan 24, 2020)

Medical innovation is racing ahead of healthcare’s ability to innovate on payments, but new ideas are emerging
Advancing RWE together with academia

Katie Osborne, (Jan 2, 2020)

Pharma can realise the potential of RWE faster by collaborating more effectively with academia but first it must build trust

More Market Access

Patients and Medical

Building a health equity culture

Andrew Stone, (Nov 17, 2020)

Health inequities, often a legacy of racism, lie heavy on the healthcare sector in the US and beyond. Fixing the problem will require long-term effort on multiple fronts
Digital companions: helping improve patient treatment journeys

Katie Osborne, (Oct 23, 2020)

The virtual health explosion isn't going away. This just at the start of an era of digital enhancement
Racially diverse clinical trials: A new patient-led legacy takes root

Andrew Stone, (Oct 15, 2020)

Attempts to make trials more diverse aren’t working. To overcome far-reaching inequality and deep distrust, pharma must be educated by, as well as educate, under-served communities
Patient engagement: Breaking through in digital

Andrew Stone, (Oct 14, 2020)

The pandemic is serving as an accelerated lesson in the possibilities of digital engagement. Now pharma must work out how to harness its full potential
Amplifying the patient voice in rare disease access

Elly Aylwin-Foster, (Oct 2, 2020)

Rare disease patients are organising like never before, turning up the publicity volume and becoming ever more active in driving cures in the lab and even the boardroom